From Citizendium
Jump to navigation Jump to search
This article is a stub and thus not approved.
Main Article
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
This editable Main Article is under development and subject to a disclaimer.

In medicine, alfuzosin is a selective antagonist of alpha1-adrenergic receptors.


Uroxatral brand of alfuzosin was approved by the Food and Drug Administration in the United States of America with a New Drug Application (NDA) in 2003.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2009.[2]

External links

The most up-to-date information about Alfuzosin and other drugs can be found at the following sites.


  1. Drugs@FDA. U S Food and Drug Administration
  2. Drugs@FDA. U S Food and Drug Administration